[{"data":1,"prerenderedAt":21},["ShallowReactive",2],{"notifications-general-de":3,"compound-H4CBD(S)-de":4},"Wegen der Sommerferien arbeitet das Labor vom 22. Juli bis 9. August 2026 nach einem geänderten Zeitplan. Analyseergebnisse sind 7 bis 10 Tage nach Proben­eingang verfügbar. Vielen Dank für Ihr Verständnis.",{"name":5,"shortname":6,"synonyms":7,"cas":8,"molMass":9,"pubchemLink":10,"structure":11,"important":12,"synthetic":12,"compoundClass":13,"asociationImage":16,"summarySet":17,"compoundEffectSet":20},"S-Tetrahydrocannibidiol","H4CBD(S)",null,"4460-20-2",318.501,"https:\u002F\u002Fpubchem.ncbi.nlm.nih.gov\u002Fcompound\u002F616324","science\u002Fstructures\u002FH4CBDS-S-Tetrahydrocannibidiol_HNV61k7.png",true,{"id":14,"description":15},"2","Cannabinoids","",[18],{"summaryText":19,"language":7},"\u003Cp>Hexahydrocannabidiol, or H4CBD, is a synthesized cannabinoid created by adding four hydrogen atoms to the CBD molecule. The process used to make H4CBD is very similar to making margarine from vegetable oil. The exact properties of H4CBD remain unknown, but the limited information available on this cannabinoid indicates that it has considerably higher affinity for your brain’s CB1 neuroreceptors than conventional CBD. Since CBD normally does not typically have any affinity for CB1 receptors, it is unclear what to make of this data. Nonetheless, people who use H4CBD generally report that it feels like CBD but with considerably higher psychoactivity. The diastereomers of H4CBD can be separated by supercritical fluid cromatography, with H4CBD(S) being slightly less energetically favored.\u003Cbr>\u003C\u002Fp>",[],1785925849685]